[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ocular-hyperemia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ocular-hyperemia":59},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100643646",false,"NCT07578363","An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults","A Multicenter, Randomized, Vehicle-Controlled Evaluation of the Efficacy and Safety of FID 123472 Ophthalmic Solution for the Reduction of Ocular Redness in Adult Subjects","Key Inclusion Criteria:\n\n* Capable of giving signed informed consent and comply with the requirements listed in the Informed Consent Form.\n* Willing and able to follow all instructions and attend all study visits.\n* History of redness relief eyedrop use within the last 6 months, or an interest in using over-the-counter redness relief drops, or would benefit from the use of redness relief drops in the investigator's opinion.\n* Baseline ocular redness score greater than 1 unit on a 5-point scale in both eyes prior to randomization.\n* Other protocol-defined inclusion criteria may apply.\n\nKey Exclusion Criteria:\n\n* Known contraindications or sensitivity to the use of any of the study treatment(s) or their components, or any other medication required by the protocol.\n* Ocular surgical interventions within 6 months prior to Visit 1 or during the study.\n* Any ocular condition that, in the opinion of the investigator, may compromise the subject's safety or study parameters.\n* Use of prohibited medications, devices, or treatments as specified in the protocol.\n* Out of range vital signs (blood pressure and\u002For pulse rate) as defined in the study protocol.\n* Abnormal intraocular pressure.\n* Other protocol-defined exclusion criteria may apply.","ALL","18 Years",{"count":18,"type":19},178,"ESTIMATED","INTERVENTIONAL",[22],"PHASE3","The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness caused by minor eye irritations.",[25],"Ocular Hyperemia",[27],"Ocular Redness","NOT_YET_RECRUITING","2026-06-08",{"date":31,"type":32},"2026-06-10","ACTUAL",{"date":34,"type":19},"2026-09",{"date":36,"type":19},"2027-03",{"name":38,"class":39},"Alcon Research","INDUSTRY",1,{"id":42,"slug":4,"hasResults":10,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":20,"phases":49,"briefSummary":50,"conditions":51,"keywords":52,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":53,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":40},"100633773","NCT07531043","Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults","A Two-Arm Multicenter Clinical Trial to Investigate Efficacy and Safety of FID123472 Ophthalmic Solution Compared With Vehicle in Adult Subjects With Ocular Redness","Key Inclusion Criteria:\n\n* Capable of giving signed informed consent and comply with the requirements listed in the Informed Consent Form.\n* Willing and able to follow all instructions and attend all study visits.\n* History of redness relief eyedrop use within the last 6 months, or an interest in using over-the-counter redness relief drops, or would benefit from the use of redness relief drops in the investigator's opinion.\n* Baseline investigator-assessed ocular redness score of greater than 1 on a 5-point scale in both eyes prior to randomization on Day 1 (Visit 2).\n* Other protocol-defined inclusion criteria may apply.\n\nKey Exclusion Criteria:\n\n* Known contraindications or sensitivity to the use of any of the investigational product(s) or their components, or any other medication required by the protocol.\n* Ocular surgical intervention within 6 months prior to Visit 1 or during the study.\n* Any ocular condition that, in the opinion of the investigator, may compromise the subject's safety or study specific parameters.\n* Use of any of the prohibited medications or devices as specified in the study protocol.\n* Out-of-range vital signs (blood pressure and\u002For pulse rate) as defined in the study protocol.\n* Abnormal intraocular pressure.\n* Other protocol-defined exclusion criteria may apply.",{"count":48,"type":19},230,[22],"The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness due to minor eye irritations.",[25],[27],{"date":31,"type":32},{"date":55,"type":19},"2026-10",{"date":57,"type":19},"2027-02",{"name":38,"class":39},""]